Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system

被引:7
作者
Duarte, Gustavo de Carvalho [1 ,2 ]
Fujita Neto, Francisco Guilherme [1 ,2 ]
Comenalli Marques Junior, Jose Francisco [1 ]
Langhi, Dante Mario [1 ]
机构
[1] H Hemo Hemoterapia Brasil SA, Sao Paulo, SP, Brazil
[2] Fujisan, Fortaleza, Ceara, Brazil
关键词
Transfusion medicine; Blood transfusion; Transfusion reaction; Patient care management; Medical audit; CELL TRANSFUSION;
D O I
10.1016/j.htct.2020.12.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Patient blood management (PBM) programs are associated with better patient outcomes, a reduced number of transfusions and cost-savings The Clinical Decision Support (CDS) systems are valuable tools in this process, but their availability is limited in developing countries This study assesses the feasibility and effectiveness of an adapted CDS system for low-income countries. Methods: This was a prospective study of the PBM program implementation, in a 200-bed tertiary hospital, between February 2019 and May 2020. Outcome measures were red blood cell (RBC), fresh frozen plasma (FFP) and platelet unit transfusions, the transfusion of a single unit of red blood cells and an RBC adequacy index (RAI). Results: Comparing the post-PBM program era with the pre-PBM system era, there was a decrease in red blood cell transfusions (p = 0.05), with an increase in single unit red blood cell transfusions (p = 0.005) and RAI (p < 0.001). Conclusions: The PBM programs, including electronic transfusion guidelines with pretransfusion medical auditing, was associated with improved transfusion practices and reduced product acquisition-related costs. (C) 2021 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.
引用
收藏
页码:374 / 378
页数:5
相关论文
共 17 条
[1]  
[Anonymous], 2013, APPROPRIATE USE MED
[2]  
Benites BD, 2019, ISBT SCI SER, V14, P218
[3]   Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignancies [J].
Bowman, Zelia ;
Fei, Naomi ;
Ahn, Janice ;
Wen, Sijin ;
Cumpston, Aaron ;
Shah, Nilay ;
Craig, Michael ;
Perrotta, Peter L. ;
Kanate, Abraham S. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) :383-388
[4]   Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals [J].
Bruun, M. T. ;
Pendry, K. ;
Georgsen, J. ;
Manzini, P. ;
Lorenzi, M. ;
Wikman, A. ;
Borg-Aquilina, D. ;
van Pampus, E. ;
van Kraaij, M. ;
Fischer, D. ;
Meybohm, P. ;
Zacharowski, K. ;
Geisen, C. ;
Seifried, E. ;
Liumbruno, G. M. ;
Follea, G. ;
Grant-Casey, J. ;
Babra, P. ;
Murphy, M. F. .
VOX SANGUINIS, 2016, 111 (04) :391-398
[5]   The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine [J].
Callum, Jeannie L. ;
Waters, Jonathan H. ;
Shaz, Beth H. ;
Sloan, Steven R. ;
Murphy, Michael F. .
TRANSFUSION, 2014, 54 (09) :2344-2352
[6]   Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB [J].
Carson, Jeffrey L. ;
Grossman, Brenda J. ;
Kleinman, Steven ;
Tinmouth, Alan T. ;
Marques, Marisa B. ;
Fung, Mark K. ;
Holcomb, John B. ;
Illoh, Orieji ;
Kaplan, Lewis J. ;
Katz, Louis M. ;
Rao, Sunil V. ;
Roback, John D. ;
Shander, Aryeh ;
Tobian, Aaron A. R. ;
Weinstein, Robert ;
McLaughlin, Lisa Grace Swinton ;
Djulbegovic, Benjamin .
ANNALS OF INTERNAL MEDICINE, 2012, 157 (01) :49-U95
[7]  
Souza Diego Agra de, 2013, Rev. Bras. Hematol. Hemoter., V35, P263, DOI 10.5581/1516-8484.20130070
[8]  
Duarte GC, 2014, TRANSFUSION, V54, p56A
[9]  
Duarte GD, 2018, HEMASPHERE, V2, P344
[10]  
Fredrich N, 2019, PBM METRICS, P1